Gliclazide, Metformin, and Rosiglitazone are used in the treatment of type 2 diabetes mellitus.
How Gliclazide, Metformin, and Rosiglitazone Work Gliclazide, Metformin, and Rosiglitazone is a combination of three antidiabetic medications: Gliclazide, Metformin, and Rosiglitazone. They work through different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Gliclazide is a sulfonylurea that increases the amount of insulin released by the pancreas to lower blood glucose levels. Metformin is a biguanide that reduces glucose production in the liver, delays glucose absorption from the intestines, and enhances the body's sensitivity to insulin. Rosiglitazone is a thiazolidinedione that further increases insulin sensitivity.
Common side effects of Gliclazide, Metformin, and Rosiglitazone include hypoglycemia (low blood glucose level), nausea, taste changes, diarrhea, stomach pain, headache, edema (swelling), weight gain, blurred vision, bone fractures, and respiratory tract infections.